Curis Hedgehog and Beyond --plus multi-targeting cancer inhibitors
Novel Anti-Cancer therapies
It is currently Thu Jul 29, 2010 12:12 pm
Curis Hedgehog and Beyond --plus multi-targeting cancer inhibitors
News of Curis Hedgehog and Beyond --plus multi-targeting cancer inhibitors » Curis Hedgehog and Beyond --plus multi-targeting cancer inhibitors
Novel Anti-Cancer therapies-
- What is the Hedgehog Pathway?
- What is the Hedgehog Pathway?
-
-
News of Hedgehog Pathway Cancer and Metastasis
Site map of Hedgehog Pathway Cancer and Metastasis
Topics and information of how the Hedgehog pathway tells cells to get up and move (Metastasis)
-
-
-
News of Hedgehog Pathway Clinical Implications Site map of Hedgehog Pathway Clinical Implications
Hedgehog Pathway Clinical Implications
Agonist (hair & neuronal) / Antagonist (cancers) / Embryonic Stem Cells
-
-
-
News of Hedgehog Pathway Cancers Clinical Trials Site map of Hedgehog Pathway Cancers Clinical Trials
List of Clinical Hedgehog Pathway Cancers
-
-
-
News of Hedgehog Pathway Related Cancers Site map of Hedgehog Pathway Related Cancers
List of Hedgehog Pathway Related Cancers
-
-
-
News of Hedgehog Pathway Articles Site map of Hedgehog Pathway Articles
A list of important clinical related articles
-
-
- CUDC-101 (HDAC/EGFR/Her2 inhibitor) & HSP90 Debio-0932 (CUDC-305)
- CUDC-101 (HDAC/EGFR/Her2 inhibitor) & HSP90 Debio-0932 (CUDC-305)
-
-
News of CUDC-101 (HDAC/EGFR/Her2 inhibitor) Site map of CUDC-101 (HDAC/EGFR/Her2 inhibitor)
Topics surrounding a novel approach to fighting cancers
-
-
-
News of HSP90 Debio-0932 (CUDC-305) Site map of HSP90 Debio-0932 (CUDC-305)
Debio 0932 (formerly CUDC-305) is a small molecule inhibitor of Heat Shock Protein 90 (Hsp90). Debio0932 is expected to enter Phase I clinical testing in early Q1 2010.
-
Last 15 active topics
Statistics
Total posts 31 • Total topics 21 • Total members 10
SitemapIndex
RSS Feed